Hemotune AG
HemoSystem is a blood purification platform with much higher efficiency and precision compared to existing methods. It mixes nanoengineered magnetic beads directly with patients’ blood in a dialysis-like machine where they bind to selected targets.
Hemotune AG has raised €7.1M across 1 funding round from 5 investors, most recently a Series B round in Apr 2022. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Zurich, Switzerlandwww.hemotune.ch ↗
Total raised
€7.1M
€7,087,692
Funding rounds
1
Investors
5
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearHemotune AG — funding by year — interactive chart.
Data table
| Hemotune AG — funding by year | |
|---|---|
| 2022 | €7.1M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-26 | Series B | €7.1M | Hemex,OCCIDENT,Private investor,VP Venture Partners,Zürcher Kantonalbank | View deal → |
Investors
5Related news
- CHF 7.25 million for a platform reducing the burden of sepsisstartupticker.ch · 2022-04
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData